Logo image of IBN

ICICI BANK LTD-SPON ADR (IBN) Stock Fundamental Analysis

NYSE:IBN - New York Stock Exchange, Inc. - US45104G1040 - ADR - Currency: USD

34.1  -0.15 (-0.44%)

After market: 34.29 +0.19 (+0.56%)

Fundamental Rating

4

IBN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 396 industry peers in the Banks industry. IBN has a medium profitability rating, but doesn't score so well on its financial health evaluation. IBN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year IBN was profitable.
In the past year IBN had a positive cash flow from operations.
Each year in the past 5 years IBN has been profitable.
IBN had a positive operating cash flow in 4 of the past 5 years.
IBN Yearly Net Income VS EBIT VS OCF VS FCFIBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B 1T 1.5T

1.2 Ratios

IBN has a Return On Assets of 1.93%. This is amongst the best in the industry. IBN outperforms 96.21% of its industry peers.
IBN's Return On Equity of 16.26% is amongst the best of the industry. IBN outperforms 94.70% of its industry peers.
Industry RankSector Rank
ROA 1.93%
ROE 16.26%
ROIC N/A
ROA(3y)1.85%
ROA(5y)1.63%
ROE(3y)16.47%
ROE(5y)14.97%
ROIC(3y)N/A
ROIC(5y)N/A
IBN Yearly ROA, ROE, ROICIBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

The Profit Margin of IBN (24.82%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of IBN has grown nicely.
The Operating Margin and Gross Margin are not available for IBN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 24.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.78%
PM growth 5Y22.23%
GM growth 3YN/A
GM growth 5YN/A
IBN Yearly Profit, Operating, Gross MarginsIBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

2

2. Health

2.1 Basic Checks

IBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IBN has been increased compared to 1 year ago.
The number of shares outstanding for IBN has been increased compared to 5 years ago.
IBN has a better debt/assets ratio than last year.
IBN Yearly Shares OutstandingIBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
IBN Yearly Total Debt VS Total AssetsIBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5T 10T 15T 20T 25T

2.2 Solvency

IBN has a debt to FCF ratio of 1.85. This is a very positive value and a sign of high solvency as it would only need 1.85 years to pay back of all of its debts.
IBN has a Debt to FCF ratio of 1.85. This is comparable to the rest of the industry: IBN outperforms 51.52% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that IBN is somewhat dependend on debt financing.
IBN has a worse Debt to Equity ratio (0.70) than 82.32% of its industry peers.
Although IBN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 1.85
Altman-Z N/A
ROIC/WACCN/A
WACC4.41%
IBN Yearly LT Debt VS Equity VS FCFIBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1T 2T 3T

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
IBN Yearly Current Assets VS Current LiabilitesIBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.97% over the past year.
IBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.43% yearly.
IBN shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.94%.
Measured over the past years, IBN shows a quite strong growth in Revenue. The Revenue has been growing by 14.35% on average per year.
EPS 1Y (TTM)14.97%
EPS 3Y25.97%
EPS 5Y40.43%
EPS Q2Q%17.41%
Revenue 1Y (TTM)26.94%
Revenue growth 3Y20.88%
Revenue growth 5Y14.35%
Sales Q2Q%11%

3.2 Future

IBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.60% yearly.
The Revenue is expected to grow by 15.15% on average over the next years. This is quite good.
EPS Next Y9.59%
EPS Next 2Y11.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11%
Revenue Next 2Y12.77%
Revenue Next 3Y15.15%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IBN Yearly Revenue VS EstimatesIBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500B 1T 1.5T 2T
IBN Yearly EPS VS EstimatesIBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

2

4. Valuation

4.1 Price/Earnings Ratio

IBN is valuated rather expensively with a Price/Earnings ratio of 22.29.
IBN's Price/Earnings ratio is rather expensive when compared to the industry. IBN is more expensive than 81.31% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.04, IBN is valued a bit cheaper.
A Price/Forward Earnings ratio of 20.30 indicates a rather expensive valuation of IBN.
IBN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. IBN is more expensive than 79.04% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.64, IBN is valued a bit cheaper.
Industry RankSector Rank
PE 22.29
Fwd PE 20.3
IBN Price Earnings VS Forward Price EarningsIBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, IBN is valued a bit cheaper than the industry average as 74.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.9
EV/EBITDA N/A
IBN Per share dataIBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.32
PEG (5Y)0.55
EPS Next 2Y11.6%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.76%, IBN is not a good candidate for dividend investing.
With a Dividend Yield of 0.76, IBN pays less dividend than the industry average, which is at 3.27. 84.34% of the companies listed in the same industry pay a better dividend than IBN!
With a Dividend Yield of 0.76, IBN pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

The dividend of IBN is nicely growing with an annual growth rate of 48.58%!
IBN has paid a dividend for at least 10 years, which is a reliable track record.
IBN has decreased its dividend recently.
Dividend Growth(5Y)48.58%
Div Incr Years1
Div Non Decr Years1
IBN Yearly Dividends per shareIBN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 50 100 150 200

5.3 Sustainability

13.80% of the earnings are spent on dividend by IBN. This is a low number and sustainable payout ratio.
The dividend of IBN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP13.8%
EPS Next 2Y11.6%
EPS Next 3YN/A
IBN Yearly Income VS Free CF VS DividendIBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500B 1T 1.5T
IBN Dividend Payout.IBN Dividend Payout, showing the Payout Ratio.IBN Dividend Payout.PayoutRetained Earnings

ICICI BANK LTD-SPON ADR

NYSE:IBN (7/25/2025, 8:04:00 PM)

After market: 34.29 +0.19 (+0.56%)

34.1

-0.15 (-0.44%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-19 2025-04-19/amc
Earnings (Next)07-25 2025-07-25
Inst Owners51.7%
Inst Owner Change0.11%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap121.66B
Analysts87.44
Price Target38.83 (13.87%)
Short Float %0.64%
Short Ratio4.87
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.23
Dividend Growth(5Y)48.58%
DP13.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-12 2025-08-12 (11)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.25%
Min EPS beat(2)1.18%
Max EPS beat(2)3.31%
EPS beat(4)4
Avg EPS beat(4)3.19%
Min EPS beat(4)1.18%
Max EPS beat(4)4.73%
EPS beat(8)8
Avg EPS beat(8)3.57%
EPS beat(12)9
Avg EPS beat(12)2.36%
EPS beat(16)11
Avg EPS beat(16)1.24%
Revenue beat(2)0
Avg Revenue beat(2)-1.89%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.37%
Min Revenue beat(4)-4.62%
Max Revenue beat(4)-1.11%
Revenue beat(8)2
Avg Revenue beat(8)3.12%
Revenue beat(12)6
Avg Revenue beat(12)43.15%
Revenue beat(16)10
Avg Revenue beat(16)68.09%
PT rev (1m)-0.28%
PT rev (3m)8.5%
EPS NQ rev (1m)1.22%
EPS NQ rev (3m)3.27%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-0.32%
Revenue NQ rev (1m)2.2%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.76%
Valuation
Industry RankSector Rank
PE 22.29
Fwd PE 20.3
P/S 5.11
P/FCF 8.9
P/OCF 8.56
P/B 3.35
P/tB 3.44
EV/EBITDA N/A
EPS(TTM)1.53
EY4.49%
EPS(NY)1.68
Fwd EY4.93%
FCF(TTM)3.83
FCFY11.23%
OCF(TTM)3.98
OCFY11.68%
SpS6.67
BVpS10.18
TBVpS9.91
PEG (NY)2.32
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 16.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 24.82%
GM N/A
FCFM 57.42%
ROA(3y)1.85%
ROA(5y)1.63%
ROE(3y)16.47%
ROE(5y)14.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.78%
PM growth 5Y22.23%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 1.85
Debt/EBITDA N/A
Cap/Depr 177.3%
Cap/Sales 2.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 231.31%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC4.41%
ROIC/WACCN/A
Cap/Depr(3y)170.52%
Cap/Depr(5y)150.4%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.97%
EPS 3Y25.97%
EPS 5Y40.43%
EPS Q2Q%17.41%
EPS Next Y9.59%
EPS Next 2Y11.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.94%
Revenue growth 3Y20.88%
Revenue growth 5Y14.35%
Sales Q2Q%11%
Revenue Next Year11%
Revenue Next 2Y12.77%
Revenue Next 3Y15.15%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.54%
FCF growth 3Y28.45%
FCF growth 5Y8.72%
OCF growth 1Y-22.3%
OCF growth 3Y28.74%
OCF growth 5Y9.07%